LifeMD (LFMD) news
Recent news
Lifemd, Inc.: H.C. Wainwright cuts target price to $9 from $10
H.C. Wainwright has revised its price target for LifeMD, Inc. (NASDAQ: LFMD) to $9 from $10, while maintaining a "Buy" rating . The adjustment follows the company’s recent financial report and broader market dynamics. LifeMD’s stock currently trades at $3.91, reflecting a 34% decline . For the…
AInvest Wire · Aug 7, 2026Lifemd Inc Q3 rev view $58.6 mln -- LSEG Ibes data
AInvest Wire · Aug 5, 2026Lifemd Inc FY2026 rev view $222.1 mln -- LSEG Ibes data
AInvest Wire · Aug 5, 2026LifeMD Inc outlook Q3 revenue $48 million to $51 million
LifeMD Inc. has provided an updated revenue outlook for the third quarter of 2026, projecting earnings in the range of $48 million to $51 million. This forecast reflects the company’s continued focus on expanding its direct-to-patient telehealth services, which aim to deliver accessible and…
AInvest Wire · Aug 5, 2026LifeMD Inc outlook FY revenue USD 205.5-212.5 million
LifeMD Inc. (NASDAQ:LFMD) has provided an updated revenue outlook for the fiscal year, projecting earnings between USD 205.5 million and USD 212.5 million. This forecast reflects continued growth following the company’s strong performance in FY 2023, during which revenue reached USD 152.5 million ,…
AInvest Wire · Aug 5, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.